Latest Breaking News On - Subjective outcomes - Page 1 : comparemela.com

Apnimed Presented Positive Phase 2b Results on AD109, an Investigational Oral Drug for Obstructive Sleep Apnea, for the First Time at ATS 2023

Apnimed Presented Positive Phase 2b Results on AD109, an Investigational Oral Drug for Obstructive Sleep Apnea, for the First Time at ATS 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomLarry millerAmanda breedingscientPaula schweitzerResearch centerInternational conferenceApnimed incDrug administrationResearch at stData showedSignificantly improvedBoth objectiveSubjective outcomesSupport advancingBreaking news

Apnimed to Present Data on Drug Candidate for Sleep Apnea

Data from Apnimed’s MARIPOSA phase 2b trial of its drug candidate for OSA will be featured at the ATS 2023 International Conference.

United statesLarry millerPaula schweitzerHuy phoResearch centerInternational conferenceWaltere washington convention centerDrug administrationAmerican thoracic societyHoral agentSubjective outcomesObstructive sleep apneaControlled clinicalBreaking newsNew approachesNew trials mini symposium